In SCLC, sensitivity to LSD1 inhibitors is linked to neuroendocrine transcriptional programs, whereas resistance correlates with a TEAD4-driven mesenchymal-like state as mentioned earlier (113). This evidence concerns the gene KDM1A and small cell lung carcinoma.